Clearmind Medicine Inc. Common Shares (NASDAQ:CMND) — Stock Price
Clearmind Medicine Inc. Common Shares (NASDAQ:CMND) is currently trading at $1.60 USD, down 1.84% today. Over the past 52 weeks, shares have ranged between $0.07 and $3.98. This page tracks Clearmind Medicine Inc. Common Shares's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Clearmind Medicine Inc. Common Shares worth.
Clearmind Medicine Inc. Common Shares (CMND) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Clearmind Medicine Inc. Common Shares's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Clearmind Medicine Inc. Common Shares Income Statement — Revenue, Profit & Earnings by Year
Clearmind Medicine Inc. Common Shares's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $49.36K | $71.09K | $79.06K | $119.62K | $2.53K |
| Gross Profit | $-49.36K | $-71.09K | $-79.06K | $-119.62K | $-2.53K |
| Research & Development | $2.05 Million | $1.91 Million | $2.11 Million | $4.42 Million | $635.40K |
| SG&A | $3.57 Million | $3.26 Million | $6.60 Million | $5.43 Million | $3.03 Million |
| Total Operating Expenses | $5.62 Million | $7.93 Million | $8.59 Million | $8.88 Million | $3.61 Million |
| Operating Income | $-5.67 Million | $-8.00 Million | $-8.67 Million | $-9.00 Million | $-3.61 Million |
| EBITDA | $-3.72 Million | $-6.67 Million | $-11.75 Million | $-9.75 Million | $-3.65 Million |
| EBIT | $-3.77 Million | $-6.74 Million | $-11.83 Million | $-9.86 Million | $-3.66 Million |
| Interest Expense | $19.54K | $50.34K | $10.89K | $20.76K | $446.44K |
| Income Before Tax | $-3.79 Million | $-6.79 Million | $-11.83 Million | $-9.89 Million | $-3.66 Million |
| Income Tax Expense | $70.44K | $526.13K | $23.88K | $42.99K | $223.22K |
| Net Income | $-3.86 Million | $-7.31 Million | $-11.85 Million | $-9.93 Million | $-3.66 Million |
Clearmind Medicine Inc. Common Shares Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Clearmind Medicine Inc. Common Shares's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $6.08 Million | $10.10 Million | $5.95 Million | $1.12 Million | $4.16 Million |
| Total Current Assets | $5.95 Million | $9.87 Million | $5.79 Million | $590.01K | $3.97 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | $1.66 Million | $402.83K | $86.11K | $262.98K | $0.00 |
| Net Receivables | $322.28K | $251.78K | $240.32K | $132.91K | $129.80K |
| Inventory | — | — | $-40.74K | — | — |
| Property, Plant & Equipment | — | — | — | $66.38K | $20.58K |
| Goodwill | — | — | $-873.00 | — | — |
| Total Liabilities | $4.89 Million | $5.77 Million | $4.97 Million | $2.62 Million | $288.19K |
| Total Current Liabilities | $4.89 Million | $5.75 Million | $4.97 Million | $2.62 Million | $288.19K |
| Long-term Debt | — | — | — | — | — |
| Net Debt | $-2.14 Million | $-9.08 Million | $-5.43 Million | $-122.68K | $-3.71 Million |
| Total Stockholder Equity | $1.19 Million | $4.33 Million | $983.47K | $-1.50 Million | $3.87 Million |
| Retained Earnings | $-27.88 Million | $-33.44 Million | $-18.77 Million | $-13.77 Million | $-3.58 Million |
Clearmind Medicine Inc. Common Shares Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Clearmind Medicine Inc. Common Shares generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-4.73 Million | $-6.76 Million | $-6.30 Million | $-5.06 Million | $-2.08 Million |
| Capital Expenditures | $0.00 | $0.00 | $0.00 | $7.55K | $169.38K |
| Free Cash Flow | $-4.73 Million | $-6.76 Million | $-6.30 Million | $-5.06 Million | $-2.25 Million |
| Investing Cash Flow | $-541.97K | $-331.43K | $-26.23K | $-7.55K | $-184.03K |
| Financing Cash Flow | $2.62 Million | $8.71 Million | $11.66 Million | $694.52K | $5.39 Million |
| Dividends Paid | — | — | — | $0.00 | $0.00 |
| Stock-Based Compensation | $805.82K | $1.39 Million | $366.40K | $1.64 Million | $619.94K |
| Depreciation | $49.36K | $71.09K | $57.51K | $112.75K | $1.88K |
| Change in Cash | $-2.65 Million | $1.60 Million | $5.30 Million | $-4.40 Million | $3.13 Million |
Clearmind Medicine Inc. Common Shares Earnings History — EPS Actual vs. Analyst Estimates
Track Clearmind Medicine Inc. Common Shares's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jan 31, 2026 | -3.32 | — | — |
| Jan 20, 2026 | -5.03 | — | — |
| Sep 11, 2025 | -9.84 | — | — |
| Jun 12, 2025 | -0.16 | — | — |
| Mar 13, 2025 | -0.24 | — | — |
| Oct 31, 2024 | -8.30 | — | — |
| Jul 31, 2024 | -23.53 | — | — |
| Apr 30, 2024 | -0.28 | — | — |